Angiogenesis in Glioblastoma—Treatment Approaches
Glioblastoma, the most common primary malignant brain tumor in adults, carries a poor prognosis, with a median survival of just 15 months, significantly impacting patients’ quality of life. The aggressive growth of these highly vascularized tumors relies heavily on angiogenesis, driven primarily by...
Saved in:
| Main Authors: | Agnieszka Nowacka, Maciej Śniegocki, Wojciech Smuczyński, Dominika Bożiłow, Ewa Ziółkowska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/6/407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential of Curcumin and Its Analogs in Glioblastoma Therapy
by: Agnieszka Nowacka, et al.
Published: (2025-03-01) -
Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma
by: Alexander Scholz, et al.
Published: (2015-12-01) -
Sirtuins in Central Nervous System Tumors—Molecular Mechanisms and Therapeutic Targeting
by: Agnieszka Nowacka, et al.
Published: (2025-07-01) -
The Adverse Effects and Use of Bevacizumab in Patients with Glioblastoma: A Systematic Review and Meta-Analysis
by: Alejandro Bruna-Mejías, et al.
Published: (2025-05-01) -
Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication
by: Yulong Han, et al.
Published: (2025-11-01)